Clinical Trial Update: Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating whether maintenance corticosteroid treatment can be discontinued in patients with quiescent systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Corticosteroids (maintenance therapy) (Corticosteroids)

Snippet

Sponsor: Groupe Hospitalier Pitie-Salpetriere | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: UNKNOWN